Issue |
J Oral Med Oral Surg
Volume 29, Number 4, 2023
|
|
---|---|---|
Article Number | 40 | |
Number of page(s) | 5 | |
DOI | https://doi.org/10.1051/mbcb/2023037 | |
Published online | 23 January 2024 |
Case Report
Oral lichen planus pemphigoid : a case report of a rare disease treated by topical Tacrolimus mouthwash and Hydroxychloroquine
Hôpital Pellegrin, Bordeaux, France
* Correspondence: jeremydouley@gmail.com
Received:
26
October
2023
Accepted:
6
November
2023
Introduction: Oral Lichen Planus Pemphigoid (LPP) is the rare association of lichen planus and Mucous Membrane Pemphigoid (MMP) whose therapeutic lines are poorly defined. Bilateral and symmetrical reticulated white lesions characteristic of lichen planus (LP) most often precede the painful post-bullous ulcerations of pemphigoid (P). The oral LPP is very rare and the treatment is not codified. This report described a rare case of oral LPP, successfully treated with an original combo of topical Tacrolimus and hydroxychloroquine. Observation: A 72 yr old patient was referred to the unit of the oral mucosa pathology and oro-facial pain, of the oral surgery service of Bordeaux hospital. He has painful mouth ulcerations accompanied by reticulated and symmetrical white lesions. A biopsy to perform an anatomopathological examination and a direct immunofluorescence founds the anatomopathological characteristics of LP and P.As first line of treatment, local and general corticosteroid therapy was undertaken to reduce inflammation. The result was not totally satisfactory. As second line of treatment topical Tacrolimus and hydroxychloroquine made it possible to reduce drastically the patient's erosive and ulcerated lesions. Conclusion: The combination of topical tacrolimus and HCQ should be considerated as second line of treatment for LPP resistant to corticotherapy.
Key words: oral lichen planus pemphigoid / tacrolimus / hydroxychloroquine / mucous membrane memphigoid
© The authors, 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.